ArticleFrontiers in pharmacology2022

Notoginsenoside R1 Ameliorates Cardiac Lipotoxicity Through AMPK Signaling Pathway.

Xue Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.